Evaluating the Utility of Endogenous OCT2 and MATE1/2-K Biomarkers for DDI Assessment in Early Clinical Settings. Rina Nishii, Yongjun Xue, Runlan Huo, Jian Chen,Hong Shen, Yizhe Chen, Ken OgasawaraJournal of pharmaceutical sciences(2025)引用 0|浏览0AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要